The Critical Care Recovery Program: Use of a Structured Clinic Visit to Reduce Adverse Drug Events in ICU Survivors

NCT06723860 | Not Yet Recruiting

• 1 other identifier: H24-03124
• Study Type: observational
• Target: 3,000
• Locations: 0 countries
• Sites: N/A

Brief Summary

Background and Objective: Intensive Care Units (ICUs) save lives, but many ICU survivors face ongoing health issues, including adverse drug events (ADEs) from medications started during their hospital stay. These ADEs lead to emergency department visits and hospital admissions. Our project aims to improve the health of ICU survivors by creating a clinic that focuses on managing post-ICU health. The clinic will track and address medical issues that arise after ICU discharge and focus on deprescribing, or safely stopping, medications that may no longer be needed or could be harmful. Project Plan: The clinic will be set up within the CARES clinic at VGH. Patients will be enrolled when they leave the ICU and will have follow up visits after hospital discharge. During these visits, the team will review each patient's medications and develop a personalized plan to reduce or stop unnecessary medications. We will also monitor patients for any new health issues that arise and provide eduction to patients and caregivers about managing their health. Research and Evaluation: We will collect and analyze data on patient health outcomes, including the incidence of ADEs, hospital reeadmissions, and emergency department visits. We hope to show that patients who receive follow up care have better health outcomes and use fewer healthcare resources than a historical cohort. This data will help us demonstrate the cost-effectiveness of the clinic and support the need for expanding ICU follow up programs in British Columbia. Long-term goals: We plan to establish a post-ICU care working group and expand the clinic model to other hospitals. Over the long term, we hope to standardize post-ICU care across BC, ensuring that all ICU survivors have access to comprehensive follow up care. This project will also lay the groundwork for future research on deprescribing medications for ICU related complications, which tend to improve or resolve once critical illness has resolved. The CCRP clinic will provide a setting to conduct clinical deprescription trials to establish whether long-term treatment of these complications is necessary. Conclusion: Establishing a post-ICU discharge follow up clinic with a focus on deprescription has the potential to improve the long-term health and quality of life for ICU survivors. By reducing unnecessary medications, we can prevent complications, reduce hospital readmissions and demonstrate the value of comprehensive post-ICU follow up care.

Conditions

Post Intensive Care Syndrome (PICS); Polypharmacy; Adverse Drug Events; Critical Care, Intensive Care

Outcome Measures

Primary Outcomes (1)

• Days alive and out of hospital in the year following hospital discharge

  1 year

Secondary Outcomes (1)

• Emergency department visits and hospital admissions in the year following ICU admission

  1 year

Study Arms (2)

Retrospective control cohort

Retrospectively collected data on a group of intensive care survivors who were not referred for a post-ICU clinic visit.

Intervention cohort

Patients meeting FICM criteria who are referred for a CCRP clinic visit and consent to participation in research

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients meeting inclusion / exclusion criteria above (per FICM guidelines for critical care recovery program follow up)

You may qualify if:

• Patient being discharged to ward, home or repatriated to local health centre AND ONE OR MORE OF
• Duration of mechanical ventilation \>72 hours
• Length of stay in critical care \>96 hours
• Out of hospital arrest
• Maternal critical illness
• Trauma
• Significant ICU delirium
• Unexpected adverse outcomes of planned treatment

You may not qualify if:

• Patient discharged for palliative care or expected to die within the next two months

Sponsors & Collaborators

• University of British Columbia: lead

MeSH Terms

Conditions

postintensive care syndrome; Drug-Related Side Effects and Adverse Reactions

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders

Central Study Contacts

Marnie A Goodwin Wilson, MD, MSc, MPH

CONTACT

6047907627; marnie.gwilson@gmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Target Duration: 1 Year
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Clinical Assistant Professor of Medicine

Study Record Dates

• First Submitted: December 4, 2024
• First Posted: December 9, 2024
• Study Start: January 30, 2025
• Primary Completion (Estimated): December 30, 2026
• Study Completion (Estimated): December 30, 2027
• Last Updated: December 9, 2024

Record last verified: 2024-12

Data Sharing

• IPD Sharing: Will share